Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Tinnitus
99%
Bell's Palsy
37%
Facial Nerve Paralysis
33%
Sensorineural Hearing Loss
25%
Steroid
23%
Rhinoplasty
20%
Sudden Deafness
20%
Prognostic Factor
18%
Hearing Impairment
17%
Treatment Outcome
17%
Pure Tone Audiometry
17%
Ramsay Hunt Syndrome
16%
Dizziness
15%
Electroencephalography
15%
Secretory Otitis Media
15%
Retrospective Study
13%
Hyperacusis
12%
Magnetic Resonance Imaging
11%
Numeric Rating Scale
10%
Transcranial Direct Current Stimulation
10%
Benign Paroxysmal Positional Vertigo
10%
Photograph
10%
Eustachian Tube
10%
Auditory Threshold
8%
Auditory Tube Dysfunction
8%
Facial Nerve
8%
Steroid Treatment
7%
Vertigo
7%
Medical Record
6%
Allergic Rhinitis
6%
Logistic Regression Analysis
6%
Meta-Analysis
6%
Counseling
6%
Speech Production
6%
Somatics
6%
Temporal Bone
6%
Treatment Effect
6%
Chronic Otitis Media
6%
Oral
5%
Combination Therapy
5%
Contralateral
5%
Hemispheric Dominance
5%
Contralateral Side
5%
Outpatient
5%
Biological Marker
5%
Neck
5%
Therapy Effect
5%
Treatment Group
5%
Dexamethasone
5%
Antiviral Therapy
5%
Nursing and Health Professions
Tinnitus
100%
Perception Deafness
29%
Hearing Impairment
24%
Hyperacusis
18%
Pure Tone Audiometry
15%
Vestibular Neuronitis
15%
Transcranial Direct-Current Stimulation
15%
Sudden Deafness
15%
Steroid
14%
Dexamethasone
12%
Injection
12%
Numeric Rating Scale
10%
Cross-Sectional Survey
10%
Electroencephalography
10%
Nystagmus
9%
Visual Analog Scale
9%
Auditory Threshold
9%
University Hospital
8%
Confidence Interval
8%
Combination Therapy
7%
Clinical Feature
6%
Absorption Lag Time
5%
Treatment Outcome
5%
Medical Record
5%
Distortion Product Otoacoustic Emission
5%
Bell's Palsy
5%
Facial Nerve Paralysis
5%
Infection
5%
Psychologic Assessment
5%
Gerontology
5%
Counseling
5%
Pattern Recognition Receptor
5%
Optimal Drug Dose
5%
Propensity Score
5%
Endoscopic Sinus Surgery
5%
Metabolic Syndrome X
5%
Cholesteatoma
5%
Psychometry
5%
Triamcinolone
5%
Benign Paroxysmal Positional Vertigo
5%
Nuclear Magnetic Resonance Imaging
5%
Treatment Duration
5%
Methylprednisolone
5%
Nausea
5%
